These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 2208789

  • 1. In vivo boosting of lung natural killer and lymphokine-activated killer cell activity by interleukin-2: comparison of systemic, intrapleural and inhalation routes.
    Flexman JP, Manning LS, Robinson BW.
    Clin Exp Immunol; 1990 Oct; 82(1):151-6. PubMed ID: 2208789
    [Abstract] [Full Text] [Related]

  • 2. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of human NK cell and LAK cell cytotoxicity and differentiation by PGE2.
    Leung KH.
    Cell Immunol; 1989 Oct 15; 123(2):384-95. PubMed ID: 2507171
    [Abstract] [Full Text] [Related]

  • 5. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
    Tunru IS, Suzuki H, Yano S.
    Int J Cancer; 1991 Jun 19; 48(4):568-73. PubMed ID: 2045201
    [Abstract] [Full Text] [Related]

  • 6. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A.
    J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200
    [Abstract] [Full Text] [Related]

  • 7. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 8. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC, Weissler JC.
    Am J Respir Cell Mol Biol; 1989 Oct 15; 1(4):305-11. PubMed ID: 2483121
    [Abstract] [Full Text] [Related]

  • 9. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 15; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 10. Combination chemo-immunotherapy: kinetics of in vivo and in vitro generation of natural killer cells and lymphokine-activated killer cells in the rat.
    Stewart LS, Sewell HF, Thomson AW.
    Clin Exp Immunol; 1990 Mar 15; 79(3):416-23. PubMed ID: 2317946
    [Abstract] [Full Text] [Related]

  • 11. Effect of ASTA-Z 7575 (INN Maphosphamide) on human lymphokine-activated killer cell induction.
    Singh KP, Gupta RK, Shau H, Ray PK.
    Immunopharmacol Immunotoxicol; 1993 Nov 15; 15(5):525-38. PubMed ID: 8301017
    [Abstract] [Full Text] [Related]

  • 12. Intracellular calcium changes associated with in vitro lymphokine-activated killer and natural killer cell cytotoxicity.
    Burkey BB, Omann GM, Wolf GT.
    Arch Otolaryngol Head Neck Surg; 1991 Nov 15; 117(11):1281-6. PubMed ID: 1747234
    [Abstract] [Full Text] [Related]

  • 13. Isolation of human NK cells and generation of LAK activity.
    Whiteside TL.
    Curr Protoc Immunol; 2001 May 15; Chapter 7():Unit 7.7. PubMed ID: 18432847
    [Abstract] [Full Text] [Related]

  • 14. In vivo induction of lymphokine-activated killer cells by interleukin-2 splenic artery perfusion in advanced malignancy.
    Klasa RJ, Silver HK, Kong S.
    Cancer Res; 1990 Aug 15; 50(16):4906-10. PubMed ID: 2379154
    [Abstract] [Full Text] [Related]

  • 15. Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
    Margolin KA, Wright C, Forman SJ.
    Leukemia; 1997 May 15; 11(5):723-8. PubMed ID: 9180298
    [Abstract] [Full Text] [Related]

  • 16. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL, Chourmouzis E, Victorino L, MacIntyre JP, Capetola RJ, Lau CY.
    J Immunol; 1993 Sep 15; 151(6):3007-17. PubMed ID: 8376766
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice.
    Gazit Z, Kedar E.
    Cancer Immunol Immunother; 1994 Apr 15; 38(4):243-52. PubMed ID: 8168119
    [Abstract] [Full Text] [Related]

  • 18. Lymphokine-activated killer (LAK) activity to cultured rat kidney parenchymal components in vitro.
    Nietosvaara Y, Renkonen R, Mattila P, Häyry P.
    Transpl Int; 1989 Dec 15; 2(4):209-13. PubMed ID: 2627263
    [Abstract] [Full Text] [Related]

  • 19. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F, Basse PH, Hokland M.
    Nat Immun; 1989 Dec 15; 15(2-3):134-46. PubMed ID: 9162263
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.